Abstract
The rise of mucormycosis in COVID-19 patients is predisposed by indiscriminate intake of corticosteroids, poorly controlled diabetes, injury, the prolonged neutropenia, organ transplant, hemopoietic malignancies, prolonged stays in the intensive care unit and due to nosocomial infection (Raut &Huy, 2021).Oral lesions seen in COVID-19 patients are more probably caused by co-infections, adverse reactions, immunocompromised conditions instead of direct COVID-19 infection. Not every mucormycosis that occurs in the pandemic times is due to COVID-19.We would like to report 4 post-COVID-19 patients who had oral mucormycosis after covid recovery period.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
